MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

U-104

CAS No. : 178606-66-1

MCE 国际站：U-104

产品活性：U-104 (SLC-0111) 是一种有效的 CA IX 和 CA XII 碳酸酐酶 (CA) 抑制剂，K_i 值分别为 45.1 nM 和 4.5 nM。U-104 在小鼠模型中显示出明显的肿瘤生长延迟。

研究领域：Metabolic Enzyme/Protease

作用靶点：Carbonic Anhydrase

In Vitro: U-104 (SLC-0111) is a potent exosome inhibitor.
U-104 has low inhibition for CA I (K_i=5080 nM) and CA II (K_i=9640 nM).
U-104 (50 μM; for 72 hours) blocks the mesenchymal phenotype in the cancer stem cells population in hypoxia condition of 4T1 cells. U-104 (<50 μM) significantly reduces migration in a dose-dependent manner in metastatic MDA-MB-231 LM2-4^Luc+ cells , with cells growing as compact colonies similar to parental MDA-MB-231 cells.

In Vivo: U-104 (19, 38 mg/kg; daily; for 27 days) inhibits primary tumor growth in the mice implanted orthotopically with MDA-MB-231 LM2-4Luc+ cells. U-104 (19 mg/kg; daily; for 5 days) inhibits metastases formation in the 4T1 experimental metastasis mice model.
U-104 (38 mg/kg; i.p.; from 11 to 27 days) significantly delays primary tumor growth and reduces cancer stem cell population in NOD/SCID mice orthotopically implanted with MDA-MB-231 LM2-4^Luc+ cells.
U-104 (50 mg/kg; oral gavage; continuously for 4 days and suspended for 1 day; from 10 to 30 days) shows a significant delay in tumor growth in Balb/c mice orthotopically implanted with 4T1 cells.

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Peptidomimetic Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Exosomes Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Targeted Diversity Library  |  hCAIX-IN-5  |  β-Glucuronidase/hCAII-IN-1  |  Brinzolamide  |  hCAIX/XII-IN-1  |  Indisulam  |  CAII-IN-3  |  DPP IV/hCA II-IN-1  |  hCAXII-IN-2  |  CAIX/CAXII-IN-1  |  hCAI/II-IN-5  |  Girentuximab  |  Carbonic anhydrase inhibitor 9  |  hCAII-IN-7  |  Carbonic anhydrase inhibitor 8  |  Carbonic anhydrase inhibitor 4  |  Zonisamide  |  Carbonic anhydrase inhibitor 2  |  Carbonic anhydrase  |  Dichlorphenamide  |  Carbonic anhydrase inhibitor 6  |  hCAIX/XII-IN-2  |  AChE/hCA I/II-IN-1  |  Carbonic anhydrase inhibitor 3  |  hCAIX-IN-3  |  α-Glycosidase-IN-1  |  Topiramate  |  hCAII-IN-2  |  Methazolamide-d₆  |  NSC 828467

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。